Last updated on

Journal of Clinical Oncology
Research Hotspot & Journal Scope - pts


Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.15_SUPPL.3501
Prospective pooled analysis of four randomized trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months {m}) for patients (pts) with high-risk stage II colorectal cancer (CC).

Timothy Iveson · Alberto Sobrero · Takayuki Yoshino · Ioannis Sougklakos · Fang-Shu Ou · Jeffery P. Meyers · Qian Shi · Mark P Saunders · Roberto Labianca · Takeharu Yamanaka · Ioannis Boukovinas · Niels Henrik Hollander · Valter Torri · Kentaro Yamazaki · Vassilis Georgoulias · Sara Lonardi · Andrea Harkin · Gerardo Rosati · James Paul ·

Medicine
PDF
Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.15_SUPPL.9526
Phase 2 study of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with metastatic cutaneous squamous cell carcinoma (mCSCC; Group 1): 12-month follow-up.

Alexander Guminski · Annette M. Lim · Nikhil I. Khushalani · Chrysalyne D. Schmults · Leonel F. Hernandez-Aya · Badri Modi · Lara Dunn · Brett G. M. Hughes · Anne Lynn S. Chang · Axel Hauschild · Michael R. Migden · Ralf Gutzmer · Murad Alam · Vladimir Jankovic · Elizabeth Stankevich · Jocelyn Booth · S Li · Israel Lowy · Matthew G. Fury · Danny Rischin ·

Medicine
PDF
Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.15_SUPPL.8516
Ph1/2 study of Rova-T in combination with nivolumab (Nivo) ± ipilimumab (Ipi) for patients (pts) with 2L+ extensive-stage (ED) SCLC.

Jyoti Malhotra · Petros Nikolinakos · Ticiana Leal · Jonathan M. Lehman · Daniel Morgensztern · Jyoti D. Patel · John Wrangle · Giuseppe Curigliano · Eric Dansin · Laurent Greillier · Melissa L. Johnson · Neal Ready · Gilles Robinet · Satwant Lally · Shekman Wong · Emin Avsar · Ricardo Valenzuela · Charity D. Scripture · Giovanni Selvaggi · Benjamin Besse ·

Medicine
PDF
Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.4_SUPPL.191
Outcomes in pancreatic adenocarcinoma (PDA) patients (pts) with genetic alterations in DNA damage repair (DDR) pathways: Results from the Know Your Tumor (KYT) program.

Michael J. Pishvaian · Edik M. Blais · Jonathan R. Brody · Davendra Sohal · Andrew Eugene Hendifar · Vincent Chung · Sameh Mikhail · Lola Rahib · Emily E. Lyons · Lisa Tibbetts · Subha Madhavan · Lynn M. Matrisian · Emanuel F. Petricoin ·

Medicine
PDF
Journal of Clinical Oncology - DOI: 10.1200/JCO.2019.37.7_SUPPL.600
Pembrolizumab (pembro) and cabozantinib (cabo) in patients (pts) with metastatic renal cell carcinoma (mRCC): Phase I results.

Molika Emmeline Keeler · Elizabeth R. Kessler · Brandon Bernard · Sarah Weisdack · Kathryn Breaker · Mali Wold · Donna Ertz · David Weitzenkamp · Thomas W. Flaig · Elaine Tat Lam ·

Medicine
PDF

BackgroundPathophysiological concepts in delirium are not sufficient to define objective biomarkers suited to improve clinical approaches.

Delirium is associated with frequency band specific dysconnectivity in intrinsic connectivity networks: preliminary evidence from a large retrospective pilot case-control study [10.1186/s40814-018-0388-z]


7, 86% female) who were interviewed using the Clinician-Administered PTSD Scale-5 and completed self-reported measures of ER and rumination.

Emotion regulation in posttraumatic stress disorder (PTSD): Rumination accounts for the association between emotion regulation difficulties and PTSD severity. [10.1002/jclp.22879]


This study demonstrates the possibility of generating alternative actuation system concepts optimized for multifunctional requirements, not limited to small local improvements of existing architectures.

Generating potential actuation architectures for multifunctional flight control surfaces using a Design Structure Matrix clustering algorithm [10.1007/S13272-018-0332-1]


Effects were partially retained even controlling for co-occurring PTSD symptoms.

A Longitudinal Examination of the Relationship between Trauma-Related Cognitive Factors and Internalising and Externalising Psychopathology in Physically Injured Children [10.1007/s10802-018-0477-8]


Moreover, whereas SUD patients without PTSD evidenced stability in IGT performance across scripts, those with PTSD exhibited significantly lower risk-taking on the IGT following the trauma (vs.

An investigation of the effect of trauma script exposure on risk-taking among patients with substance use disorders and posttraumatic stress disorder. [10.1016/j.janxdis.2019.01.002]


Highly Related Keywords from pts

Research Hotspot

Journal of Clinical Oncology

Research Hotspot
Journal of Clinical Oncology Related Journals

Popular Journals